FPCM
BIIB icon

Financial Partners Capital Management’s Biogen BIIB Stock Holding History

Financial Partners Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-646
Closed -$224K – 120
2021
Q2 		$224K Buy
+646
New +$196K 0.04% 107
2020
Q2 		– Sell
-659
Closed -$208K – 95
2020
Q1 		$208K Buy
+659
New +$200K 0.07% 85

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Partners Capital Management's BIIB Position: Q3 2021 in Review

Financial Partners Capital Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 646 shares — an estimated $224K sold.

Financial Partners Capital Management first reported a position in BIIB in Q1 2020 and held it in 2 quarters. The position peaked at $224K in Q2 2021. 1,039 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Financial Partners Capital Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Financial Partners Capital Management sold 646 Biogen shares in Q3 2021, an estimated $224K.
  • Financial Partners Capital Management first reported a position in Biogen in Q1 2020 and held it in 2 quarters.
  • Financial Partners Capital Management's Biogen position peaked at $224K in Q2 2021.
  • 1,039 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Financial Partners Capital Management's 13F filing for Q3 2021, filed 27 Feb 2023.